NCT03954873View on ClinicalTrials.gov

Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Glucose Metabolism DisordersEndocrine or Metabolic Disease
Interventions
OTHER

Glucagon-like peptide 2

Human glucagon-like peptide 2

OTHER

Saline

Placebo

OTHER

Glucose

20% (w/v) glucose infusion for regulating plasma glucose

OTHER

Insulin

Actrapid (insulin) for lowering plasma glucose

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03954873 - Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone? | Biotech Hunter | Biotech Hunter